Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Vascular Anomaly

Tundra lists 5 Vascular Anomaly clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT04194619

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome or related, primary lower limb lymphedema, superficial arteriovenous malformations, and cerebro-spinal arteriovenous malformations) although complications of these can present life-threatening health problems for the mother and her baby. The purpose of this National prospective study is to obtain greater insight into obstetrical complications associated with rare maternal vascular genetic disorders in order to improve prevention and to reduce risk of death. In this context, experts and patient associations consider that there is a need to make real progress in the formulation of recommendations based on scientific data.

Gender: FEMALE

Ages: 18 Years - 45 Years

Updated: 2026-03-11

Vascular Anomaly
Osler Rendu Disease
Marfan Syndrome or Related
+3
ENROLLING BY INVITATION

NCT00833599

Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

The purpose of this study is to demonstrate the feasibility of near-infrared fluorescence imaging in subjects with acquired or hereditary lymphedema, in subjects with lipidema and other lymphovascular disorders and in normal health subjects; in order to attempt to correlate imaging phenotype(s) with genotype(s).

Gender: All

Ages: 3 Months - Any

Updated: 2026-03-10

1 state

Lymphedema
Lymphatic Disorders
Lipedema
+3
RECRUITING

NCT05983159

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

Recent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specific to these pathways have been developed and shown to be effective in treating cancer. This study will describe the effectiveness of (i) 48 weeks of alpelisib therapy for participants with slow-flow vascular malformations and a gene mutation in one of these signalling pathways (module 1) and (ii) 48 weeks of mirdametinib therapy for participants with fast-flow vascular malformations and a gene mutations in the other signalling pathway (module 2).

Gender: All

Ages: 2 Years - Any

Updated: 2026-02-19

1 state

Slow-Flow Vascular Malformation
Fast-Flow Vascular Malformation
Vascular Malformations
+15
RECRUITING

NCT03001180

Identification of Biomarkers for Patients with Vascular Anomalies

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Gender: All

Ages: 1 Day - Any

Updated: 2024-11-06

2 states

Vascular Anomaly
Generalized Lymphatic Anomaly
Kaposiform Hemangioendothelioma
+4
RECRUITING

NCT04464655

A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

Gender: All

Ages: 18 Years - Any

Updated: 2024-10-24

1 state

Coronary Artery Disease
Myocarditis
Infiltrative Cardiomyopathy
+7